SONOMA PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period of 5.70 thousand shares for the 6-month period ending 2020-09-30, per its 10-Q filed 2020-11-20.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod · last filed 2020-11-20
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2020-09-30 was -305.00 shares.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2020-06-30 was 6.00K shares.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2019-12-31 was 0.00 shares.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2019-09-30 was 0.00 shares, a 100.00% decline year-over-year.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 9 month |
|---|---|---|---|
| 2020-09-30 | -305.00 shares derived: 10-Q 6 month − 10-Q/A 3 month · filed 2020-11-20 | 5.70K shares 10-Q · filed 2020-11-20 | |
| 2020-06-30 | 6.00K shares 10-Q/A · filed 2020-11-17 | ||
| 2019-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-14 | 0.00 shares derived: sum of 2 quarters · filed 2020-02-14 | 0.00 shares 10-Q · filed 2020-02-14 |
| 2019-09-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-14 | 0.00 shares 10-Q · filed 2019-11-14 | |
| 2019-06-30 | 0.00 shares 10-Q · filed 2019-08-13 | ||
| 2018-12-31 | -1.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-14 | 23.00K shares derived: sum of 2 quarters · filed 2019-02-14 | 27.00K shares 10-Q · filed 2019-02-14 |
| 2018-09-30 | 24.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-11-08 | 28.00K shares 10-Q · filed 2018-11-08 | |
| 2018-06-30 | 4.00K shares 10-Q · filed 2018-08-08 | ||
| 2017-12-31 | 56.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-14 | 78.00K shares derived: sum of 2 quarters · filed 2018-02-14 | 98.00K shares 10-Q · filed 2018-02-14 |
| 2017-09-30 | 22.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-11-14 | 42.00K shares 10-Q · filed 2017-11-14 | |
| 2017-06-30 | 20.00K shares 10-Q · filed 2017-08-08 | ||
| 2016-12-31 | 22.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-02-17 | 27.00K shares derived: sum of 2 quarters · filed 2017-02-17 | 31.00K shares 10-Q · filed 2017-02-17 |
| 2016-09-30 | 5.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-15 | 9.00K shares 10-Q · filed 2016-11-15 | |
| 2016-06-30 | 4.00K shares 10-Q · filed 2016-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |